/ /

John Schieszer
Newer agent efficacious in non-metastatic castration-resistant PCa
Adding apalutamide prior to metastases may benefit men with prostate cancer who are no longer responding to androgen deprivation therapy, according to new phase III study findings.
Chemo improves QoL in men with non-metastatic, metastatic PCa
Docetaxel (Taxotere) appears to help improve overall quality of life and delay time for subsequent therapy in men with both non-metastatic and metastatic prostate cancer, according to a new analysis of STAMPEDE trial results.
How telemedicine will change care delivery and costs in 2018
Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
Cyclosporine A found efficacious for refractory IC
Cyclosporine A found efficacious for refractory IC
Long-term cyclosporine A therapy may be an effective treatment option for refractory interstitial cystitis, say researchers from Brazil.
Embolization shows promise, wide applicability in BPH
Despite a recent study’s promise, downsides to the procedure remain, according to one of the study’s authors.
Study: URS found superior to SWL in stones <1.5 cm
In renal stones smaller than 1.5 cm diameter, ureteroscopic lithotripsy (URS) is associated with superior stone-free rates compared with shock wave lithotripsy (SWL), according to a recent study.
Robotic RP associated with improved margin status
Robot-assisted radical prostatectomy may be associated with improved surgical margin status compared to open radical prostatectomy for men with intermediate-risk and high-risk prostate cancer, according to a study presented at the AUA annual meeting in Orlando, FL.
Use of robotic RN rising, despite unclear advantages
The use of robot-assisted radical nephrectomy increased by 6% over a recent 3-year period, and high-volume robotic centers for partial nephrectomy were found more likely to perform robotic radical nephrectomy despite its increased cost and similar complications to laparoscopic radical nephrectomy, according to a recent study.
Salvage extended PLND efficacious in some with prostate cancer
Salvage extended pelvic lymph node dissection (ePLND) may be highly beneficial for selected prostate cancer patients with biochemical recurrence and clinically recurrent nodal disease, say German researchers.
Nomogram may lower unneeded biopsies in men on AS
A new nomogram may help better predict the risk of disease progression in men who are being managed by active surveillance for low-risk prostate cancer.